ChemInform Abstract: Design, Synthesis, and Structure‐Activity Relationship Studies of Novel 1‐((1‐Acyl‐4‐piperidyl)methyl)‐1H‐2‐methylimidazo(4,5‐c)pyridine Derivatives as Potent, Orally Active Platelet‐Activating Factor (PAF) Antagonists. | Publicación